| 标题 |
AdvanTIG-302: Phase 3 Study of Ociperlimab (Anti-TIGIT) + Tislelizumab (Anti-PD-1) Versus Pembrolizumab in Untreated, Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥50% |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Thoracic Oncology 作者:Mark A. Socinski; Martin Reck; Luis Paz-Ares; Makoto Nishio; Alexander I. Spira; et al 出版日期:2026-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)